NRX Pharmaceuticals, Inc.
NRXP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001719406
No open-market purchases or sales by NRX Pharmaceuticals, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $47.6M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding NRX Pharmaceuticals, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 32 | 34 | +2 |
| Shares | 9.89M | 3.71M | −6.18M (−62.5%) |
| Value | $4.78M | $964.7K | −$3.82M (−79.8%) |
New holders (8)
Institutions that held NRX Pharmaceuticals, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 157,182 | $40.9K | 0.00% |
| Two Sigma Securities, LLC | 53,250 | $13.8K | 0.00% |
| Susquehanna International Group, LLP | 14,099 | $3.67K | 0.00% |
| Lido Advisors, LLC | 13,000 | $3.38K | 0.00% |
| LPL Financial LLC | 12,358 | $3.21K | 0.00% |
| XTX Topco Ltd | 11,809 | $3.07K | 0.00% |
| Hibernia Wealth Partners, LLC | 250 | $65 | 0.00% |
| Qube Research & Technologies Ltd | 165 | $43 | 0.00% |
Sold out (6)
Institutions that held NRX Pharmaceuticals, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Armistice Capital, LLC | 5,636,000 | $2.73M |
| CVI Holdings, LLC | 483,569 | $233.8K |
| Bank of America Corp | 30,000 | $14.5K |
| Jane Street Group, LLC | 15,052 | $7.28K |
| Impact Partnership Wealth, LLC | 940 | $454 |
| Citadel Advisors LLC | 247 | $119 |